Structures by: Fischer F.
Total: 34
C15H8CoF18O4P
C15H8CoF18O4P
Catalysis Science & Technology (2020) 10, 23 8005-8014
a=8.8080(9)Å b=11.2727(11)Å c=11.4608(11)Å
α=87.2767(16)° β=86.0751(16)° γ=81.5105(16)°
C18H32CoO4P
C18H32CoO4P
Catalysis Science & Technology (2020) 10, 23 8005-8014
a=9.1926(6)Å b=18.6959(12)Å c=18.8899(12)Å
α=93.315(2)° β=103.8784(19)° γ=98.222(2)°
C27H40CoO6P
C27H40CoO6P
Catalysis Science & Technology (2020) 10, 23 8005-8014
a=9.3420(4)Å b=12.6826(6)Å c=22.4709(10)Å
α=90° β=93.0410(14)° γ=90°
C24H40CoO6P
C24H40CoO6P
Catalysis Science & Technology (2020) 10, 23 8005-8014
a=10.9250(2)Å b=12.6105(2)Å c=20.1341(3)Å
α=90° β=104.5611(5)° γ=90°
C21H34CoN2O6P
C21H34CoN2O6P
Catalysis Science & Technology (2020) 10, 23 8005-8014
a=17.748(2)Å b=8.4442(11)Å c=16.239(2)Å
α=90° β=91.117(2)° γ=90°
C33H29CoNO5P
C33H29CoNO5P
Catalysis Science & Technology (2020) 10, 23 8005-8014
a=10.7864(6)Å b=11.5313(7)Å c=22.3359(13)Å
α=90° β=90° γ=90°
C68H66Dy2F42N4O12
C68H66Dy2F42N4O12
Chemical Science (2019)
a=11.7327(10)Å b=13.5801(12)Å c=14.5983(12)Å
α=71.026(4)° β=88.785(4)° γ=77.839(4)°
RS-naproxen D-proline 1:1 cocrystal, polymorph I
2(C14H14O3),2(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=12.1578(5)Å b=5.8278(2)Å c=25.6828(14)Å
α=90° β=98.762(5)° γ=90°
S-naproxen L-proline 1:1 cocrystal, polymorph II
2(C14H14O3),2(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=16.2991(7)Å b=5.8654(3)Å c=18.6876(9)Å
α=90° β=100.052(4)° γ=90°
RS-naproxen DL-proline 1:1 cocrystal, polymorph I
C14H14O3,C5H9NO2
CrystEngComm (2018) 20, 45 7308
a=9.9964(3)Å b=9.0958(4)Å c=39.9654(15)Å
α=90° β=90° γ=90°
RS-naproxen D-proline 1:1 cocrystal, polymorph II
2(C14H14O3),2(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=12.5901(6)Å b=5.7587(3)Å c=51.425(3)Å
α=90° β=90° γ=90°
RS-naproxen L-proline 1:1 cocrystal, polymorph III
2(C14H14O3),2(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=12.705(2)Å b=5.7631(8)Å c=25.000(5)Å
α=90° β=95.041(11)° γ=90°
S-naproxen ethanol solvate
C14H14O3,C2H6O
CrystEngComm (2018) 20, 45 7308
a=5.9273(2)Å b=8.7713(5)Å c=28.0747(15)Å
α=90° β=90° γ=90°
1:1 RS-naproxen D-proline cocrystal methanol solvate
2(C14H14O3),2(C5H9NO2),CH4O
CrystEngComm (2018) 20, 45 7308
a=12.9532(4)Å b=5.76337(15)Å c=25.2764(6)Å
α=90° β=93.984(3)° γ=90°
S-naproxen DL-proline 1:2 cocrystal
C14H14O3,2(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=5.8836(7)Å b=9.0952(18)Å c=44.047(10)Å
α=90° β=90° γ=90°
S-naproxen DL-proline 1:1 cocrystal
2(C14H14O3),2(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=8.84337(19)Å b=5.83510(15)Å c=33.6766(7)Å
α=90° β=91.9839(19)° γ=90°
RS-naproxen DL-proline 1:1 cocrystal, polymorph II
C14H14O3,C5H9NO2
CrystEngComm (2018) 20, 45 7308
a=34.537(4)Å b=9.0077(8)Å c=5.7183(5)Å
α=90° β=90° γ=90°
1:1 S-naproxen DL-proline cocrystal hydrate
2(C14H14O3),2(C5H9NO2),2(H2O1)
CrystEngComm (2018) 20, 45 7308
a=6.06468(13)Å b=12.2629(3)Å c=50.6290(15)Å
α=90° β=90° γ=90°
S-naproxen L-proline 2:3 cocrystal
2(C14H14O3),3(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=5.70180(10)Å b=18.8609(3)Å c=37.2392(5)Å
α=90° β=90° γ=90°
S-naproxen L-proline 1:2 cocrystal
C14H14O3,2(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=5.88160(7)Å b=8.79809(10)Å c=45.4679(5)Å
α=90° β=90° γ=90°
Cadmiumhydrogenphenylphosphonate
C12H10CdO6P2
RSC Adv. (2016)
a=16.1586(16)Å b=5.60337(54)Å c=4.46652(33)Å
α=119.6039(72)° β=94.4432(77)° γ=101.7890(80)°
Cadmiumtriphenylphosphonate
C18H19CdO9P3
RSC Adv. (2016)
a=5.7328(9)Å b=24.849(4)Å c=14.405(2)Å
α=90° β=91.123(2)° γ=90°
RS-naproxen L-proline 1:2 cocrystal
C14H14O3,2(C5H9NO2)
CrystEngComm (2018) 20, 45 7308
a=5.84172(9)Å b=8.98394(13)Å c=45.6816(8)Å
α=90° β=90° γ=90°
Theophylline:Benzamid 1:1
C7H8N4O2,C7H7NO
Acta Crystallographica Section C (2016) 72, 3 217-224
a=10.281404(12)Å b=10.281404(12)Å c=26.15892(6)Å
α=90° β=90° γ=90°
5
C26H21F18MoNO2
ACS Catalysis (2020) 14810-14823
a=12.4112(6)Å b=10.6334(6)Å c=23.3549(12)Å
α=90° β=103.504(2)° γ=90°
2
C45H46Cl2F9MoN4O,C32H12BF24
ACS Catalysis (2020) 14810-14823
a=12.8554(4)Å b=16.2503(6)Å c=19.8326(7)Å
α=105.020(2)° β=96.524(2)° γ=96.704(3)°
6
C42H43F6FeMoN3O6S2,CH2Cl2
ACS Catalysis (2020) 14810-14823
a=11.4984(6)Å b=18.3575(10)Å c=12.3063(7)Å
α=90.00° β=115.676(3)° γ=90.00°
3
C45H49F9MoN3O,C32H12BF24
ACS Catalysis (2020) 14810-14823
a=12.9087(7)Å b=16.1499(9)Å c=20.1730(11)Å
α=101.303(2)° β=101.414(3)° γ=103.356(2)°
4
C43H47F9MoN3O,C32H12BF24
ACS Catalysis (2020) 14810-14823
a=12.8175(6)Å b=15.5311(8)Å c=20.3008(10)Å
α=104.613(3)° β=96.591(3)° γ=92.480(2)°
C29H19NO2
C29H19NO2
The Journal of organic chemistry (2016) 81, 8 3087-3102
a=8.1798(2)Å b=18.7387(5)Å c=26.7480(8)Å
α=90° β=90° γ=90°
Like-[CpRe(NO){P(Me)(Ph)(C6H4o-NMe2)}]O3SMe
C21H26N2O4PReS
Journal of the American Chemical Society (2006) 128, 68-69
a=10.6147(7)Å b=11.4910(8)Å c=18.4226(12)Å
α=90.00° β=99.3850(10)° γ=90.00°
Unlike-[CpRe(NO){P(Me)(Ph)(C6H4o-NMe2)}]O3SMe
C21H26N2O4PReS
Journal of the American Chemical Society (2006) 128, 68-69
a=11.1512(7)Å b=13.6587(11)Å c=14.6425(7)Å
α=90.00° β=97.908(7)° γ=90.00°
Cp-methyl-nitrosyl-(methyl-phenyl-(o-dimethylaminophenyl)phosphine)rhenium
C21H26N2OPRe
Journal of the American Chemical Society (2006) 128, 68-69
a=8.060(2)Å b=15.729(5)Å c=8.241(3)Å
α=90.00° β=106.582(5)° γ=90.00°
1
C76H58.5BF33MoN3.5O
ACS Catalysis (2020) 14810-14823
a=12.8710(8)Å b=15.3569(10)Å c=39.432(2)Å
α=83.163(3)° β=86.320(3)° γ=89.432(4)°